Connection

JOHN LYDON to Gene Expression Regulation, Neoplastic

This is a "connection" page, showing publications JOHN LYDON has written about Gene Expression Regulation, Neoplastic.
  1. Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland. Cytokine. 2019 11; 123:154745.
    View in: PubMed
    Score: 0.352
  2. A mouse transgenic approach to induce ?-catenin signaling in a temporally controlled manner. Transgenic Res. 2011 Aug; 20(4):827-40.
    View in: PubMed
    Score: 0.195
  3. Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells. Sci Rep. 2018 09 03; 8(1):13134.
    View in: PubMed
    Score: 0.083
  4. Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis. Endocrinology. 2011 Jan; 152(1):19-25.
    View in: PubMed
    Score: 0.048
  5. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res. 2008 Jul 15; 68(14):5619-27.
    View in: PubMed
    Score: 0.041
  6. Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma. Oncogene. 2020 10; 39(40):6286-6299.
    View in: PubMed
    Score: 0.024
  7. Akt regulates progesterone receptor B-dependent transcription and angiogenesis in endometrial cancer cells. Oncogene. 2016 09 29; 35(39):5191-201.
    View in: PubMed
    Score: 0.018
  8. Estrogen-regulated prohibitin is required for mouse uterine development and adult function. Endocrinology. 2011 Mar; 152(3):1047-56.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.